Clinical Trial Update: An Open-label, Multi-center Study Evaluating the Validity, Reliability, and Responsiveness of a New Female-specific Angina Questionnaire in Women With Chronic Angina Treated With Ranolazine Extended-release Tablets (CVT 3041) [Phase 4]

View source ↗

Summary

Phase 4 open-label multicenter study evaluating the validity, reliability, and responsiveness of a new female-specific angina questionnaire in women with chroni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina

Drugs mentioned

• Ranexa (ranolazine) ER (ranolazine)

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic Angina | Phase 4 | Status: COMPLETED | Results posted: 2012-07-02